100 related articles for article (PubMed ID: 14703409)
1. [Effectiveness of recombinant adenovirus p53 injection on laryngeal cancer: phase I clinical trial and follow up].
Han DM; Huang ZG; Zhang W; Yu ZK; Wang Q; Ni X; Chen XH; Pan JH; Wang H
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2029-32. PubMed ID: 14703409
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of head and neck squamous cell carcinoma by recombinant adenovirus-p53 combined with radiotherapy: a phase II clinical trial of 42 cases].
Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Cai Y; Zhu GY; Xu B; Lü YY
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2023-8. PubMed ID: 14703408
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant adenovirus p53 agent injection combined with radiotherapy in treatment of nasopharyngeal carcinoma: a phase II clinical trial].
Chen CB; Pan JJ; Xu LY
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2033-5. PubMed ID: 14703410
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of repeated intraepithelial delivery of adenoviral p53 in patients with dysplastic oral leukoplakia.
Zhang S; Li Y; Li L; Zhang Y; Gao N; Zhang Z; Zhao H
J Oral Maxillofac Surg; 2009 May; 67(5):1074-82. PubMed ID: 19375021
[TBL] [Abstract][Full Text] [Related]
5. [Detection of p53 gene change and serum antibody level in phase II clinical trial of ad p53 gene therapy].
Zhao M; Xiao SW; Yang JX; Zhang SW; Lü YY
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3495-8. PubMed ID: 16686067
[TBL] [Abstract][Full Text] [Related]
6. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Zhu GY; Xu B
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):426-8. PubMed ID: 16188130
[TBL] [Abstract][Full Text] [Related]
7. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer.
Wolf JK; Bodurka DC; Gano JB; Deavers M; Ramondetta L; Ramirez PT; Levenback C; Gershenson DM
Gynecol Oncol; 2004 Aug; 94(2):442-8. PubMed ID: 15297186
[TBL] [Abstract][Full Text] [Related]
8. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
9. Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors.
Dummer R; Bergh J; Karlsson Y; Horowitz JA; Mulder NH; Huinink DTB ; Burg G; Hofbauer G; Osanto S
Cancer Gene Ther; 2000 Jul; 7(7):1069-76. PubMed ID: 10917210
[TBL] [Abstract][Full Text] [Related]
10. p53 gene therapy for pulmonary metastasis tumor from hepatocellular carcinoma.
Yu M; Chen W; Zhang J
Anticancer Drugs; 2010 Oct; 21(9):882-4. PubMed ID: 20679889
[TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma.
Pan JJ; Zhang SW; Chen CB; Xiao SW; Sun Y; Liu CQ; Su X; Li DM; Xu G; Xu B; Lu YY
J Clin Oncol; 2009 Feb; 27(5):799-804. PubMed ID: 19103729
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas.
Mazzolini G; Alfaro C; Sangro B; Feijoó E; Ruiz J; Benito A; Tirapu I; Arina A; Sola J; Herraiz M; Lucena F; Olagüe C; Subtil J; Quiroga J; Herrero I; Sádaba B; Bendandi M; Qian C; Prieto J; Melero I
J Clin Oncol; 2005 Feb; 23(5):999-1010. PubMed ID: 15598979
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein.
Liang ZH; Wu PH; Li L; Xue G; Zeng YX; Huang WL
Chin Med J (Engl); 2004 Dec; 117(12):1809-14. PubMed ID: 15603709
[TBL] [Abstract][Full Text] [Related]
15. Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.
Atencio IA; Grace M; Bordens R; Fritz M; Horowitz JA; Hutchins B; Indelicato S; Jacobs S; Kolz K; Maneval D; Musco ML; Shinoda J; Venook A; Wen S; Warren R
Cancer Gene Ther; 2006 Feb; 13(2):169-81. PubMed ID: 16082381
[TBL] [Abstract][Full Text] [Related]
16. Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
Xu F; Li S; Li XL; Guo Y; Zou BY; Xu R; Liao H; Zhao HY; Zhang Y; Guan ZZ; Zhang L
Cancer Gene Ther; 2009 Sep; 16(9):723-30. PubMed ID: 19363470
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of treatment of laryngeal cancer by recombinant adenovirus p53 combined with chemotherapy].
Dou X; Zhao X; Wang Y; Zeng L; Wang Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 21(18):848-50. PubMed ID: 18062290
[TBL] [Abstract][Full Text] [Related]
18. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial.
Mulvihill S; Warren R; Venook A; Adler A; Randlev B; Heise C; Kirn D
Gene Ther; 2001 Feb; 8(4):308-15. PubMed ID: 11313805
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of recurrent malignant gliomas by surgery combined with recombinant adenovirus-p53 injection].
Zhu JX; Li ZM; Geng FY; Fu Q; Guo CJ; Xiao YL; Zhang ZT; Li G
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):709-12. PubMed ID: 21122390
[TBL] [Abstract][Full Text] [Related]
20. [Clinical tolerance trial on recombinant human endostatin adenovirus].
Cao Y; Li S; Li HL; Li YH; Zhang DS; Guo Y; Li XL; Lin XB; Huang WL; Jiang WQ
Ai Zheng; 2007 Aug; 26(8):856-60. PubMed ID: 17697547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
